Drug Database
Back to search

Belgium· BE-AMP-SAM215966-00

Visudyne 15 mg

A verteporfin product containing verteporfin, registered in Belgium by Cheplapharm Arzneimittel. The same ATC class is registered in 15 of our 19 countries.

ATC S01LA01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVisudyne 15 mgATCS01LA01REGISTER NO.BE-AMP-SAM215966-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about verteporfinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Verteporfin is registered in 15 of 19 countries.

Countries holding a registration under ATC S01LA01 (verteporfin), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search verteporfin products by name

Verteporfin · ATC S01LA01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Verteporfin
Manufacturer
Cheplapharm Arzneimittel
Country
Belgium (BE)
ATC code
S01LA01
ATC class
Verteporfin
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    1552009
    EUR 941.25
  • be_apb
    0768994

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

166 interactions on record for verteporfin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check verteporfin against other medicinesHow interaction checks work

Verteporfin · interactions on record

166 records

  • 1 severe
  • 144 moderate
  • 2 minor
  • 19 info

Most severe, free to view

  • Aminolevulinic acidL01XD04severe
  • TetracyclineA01AB13moderate
  • DoxycyclineA01AB22moderate
  • MinocyclineA01AB23moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Verteporfin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All verteporfin products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Visudyne
  • Liechtenstein · Visudyne
  • Norway · Visudyne

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8eb29ab2-0b38-42b0-8818-4459ddb9117f
GET /v1/drugs/8eb29ab2-0b38-42b0-8818-4459ddb9117f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Visudyne 15 mg",
  "name_fr": "Visudyne 15 mg",
  "name_nl": "Visudyne 15 mg",
  "amp_code": "SAM215966-00",
  "strengths": [
    "15.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Verteporfin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Verteporfin",
  "authorisation_numbers": [
    "EU/1/00/140/001"
  ]
}
API referenceMCP serverPlans

See everything about verteporfin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console